Clinical Trial: Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children with ADHD: a Randomized, Placebo-Controlled Study

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06841666) titled 'Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children with ADHD: a Randomized, Placebo-Controlled Study' on Feb. 18.

Brief Summary: 1. Primary Aim: To evaluate the efficacy of atomoxetine in reducing the frequency of primary nocturnal enuresis episodes in children with ADHD.

2. Secondary Aim: To determine if improvements in attention symptoms correlate with reductions in nocturnal enuresis episodes.

Study Start Date: Feb. 28

Study Type: INTERVENTIONAL

Condition: ADHD Primary Nocturnal Enuresis

Intervention: DRUG: Atomoxetine

Atomoxetine, 0.5-1.2 mg/kg/day, administered in the evening for s...